ArticleBMJ open2022

Status migrainosus inpatient treatment with eptinezumab (SMITE): study protocol for a randomised controlled trial.

Jason Charles Ray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.